Benzodiazepine compounds useful for the treatment of hepatitis c
WO2011151651A1
Benzodiazepine compounds useful for the treatment of hepatitis c
WO2011027156A1
Benzodiazepine derivatives for treating hepatitis c infection
WO2010094977A1
Novel biphenyl compounds useful for the treatment of hepatitis c
WO2009063240A1
2,4-diaminopyrimidine derivatives useful as inhibitors of aurora kinase
WO2009034390A1
Heterocyclic derivatives and their use in treating hepatitis c
ZA200802123B
Benzodiazepine derivatives for treating hepatitis C infection
WO2008056149A1
Quinazoline derivatives and pharmaceutical compositions containing them
AU2007266915A1
Biphenyl derivatives and their use in treating hepatitis C
BRPI0706412A2
compound, use of a compound, product, pharmaceutical composition, use of an interferon or an interferon derivative, and method of treating a patient suffering or susceptible to flaviviridae infection
GB0612116D0
Chemical Compounds
GB0610663D0
Chemical compounds
GB0610664D0
Chemical compounds
GB0600510D0
Chemical compounds
GB0520475D0
Chemical compounds
KR20080059237A
Benzodiazepine derivatives for treating hepatitis c infection
AU2005336627A1
Benzodiazepine derivatives for treating hepatitis C infection
GB0518971D0
Chemical compounds
AU2005238270A1
Morpholinylanilinoquinazo- line derivatives for use as antiviral agents